Literature DB >> 28232376

Gangliocytoma: outcome of a rare silent pituitary tumour.

Bruno Donadille1, Chiara Villa2, Stephan Gaillard3, Sophie Christin-Maitre1.   

Abstract

The most common finding in front of a pituitary incidentaloma is a silent pituitary adenoma. We describe a 59 years old woman with a pituitary gangliocytoma and her follow-up after 1 year. Hormonal exploration only evidenced partial corticotropic insufficiency. A trans-sphenoidal surgery was performed due to the tumour's suprasellar expansion. Gangliocytoma is a benign tumour of unknown prevalence, belonging to central nervous system tumour with neuronal differentiation, and 129 cases have been reported in the literature. growth hormone (GH), adrenocorticotropic hormone (ACTH) or prolactin secretions have been reported, as these ganglion cell-like mature neurons are usually mixed with secreting pituitary endocrine cells. We report a case with a pure gangliocytoma devoid of symptomatic endocrine secretion, not surrounded by pituitary endocrine tumour cells. Immunochemistry of the tumour was positive for hypothalamic growth hormone releasing hormone (GHRH) and pituitary hormones, such as GH and ACTH. Hence, this immunoexpression was not associated with peripheral hormonal secretions, suggesting biologically inactive hypothalamopituitary hormones. 2017 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28232376      PMCID: PMC5337629          DOI: 10.1136/bcr-2016-218859

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  6 in total

1.  Gangliocytomas in the sellar region.

Authors:  Nidan Qiao; Zhao Ye; Yongfei Wang; Shiqi Li; Yin Mao; Weimin Bao; Xiaoming Che; Zhiyong Qin; Wei Xu; Ming Shen; Hong Chen; Xuefei Shou; Yao Zhao
Journal:  Clin Neurol Neurosurg       Date:  2014-09-07       Impact factor: 1.876

Review 2.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 3.  Management of nonfunctioning pituitary incidentaloma.

Authors:  Françoise Galland; Marie-Christine Vantyghem; Laure Cazabat; Anne Boulin; François Cotton; Jean-François Bonneville; Emmanuel Jouanneau; Gwénaelle Vidal-Trécan; Philippe Chanson
Journal:  Ann Endocrinol (Paris)       Date:  2015-06-06       Impact factor: 2.478

4.  Pituitary adenoma with gangliocytic component: report of 5 cases with focus on immunoprofile of gangliocytic component.

Authors:  Serdar Balci; Arzu Saglam; Hakan Oruckaptan; Tomris Erbas; Figen Soylemezoglu
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

Review 5.  Gangliocytomas of the sellar region: A challenging diagnosis.

Authors:  Giulia Cossu; Roy Thomas Daniel; Mahmoud Messerer
Journal:  Clin Neurol Neurosurg       Date:  2016-08-09       Impact factor: 1.876

6.  Pituitary adenoma-neuronal choristoma is a pituitary adenoma with ganglionic differentiation.

Authors:  Michaela T Nguyen; Ehud Lavi
Journal:  Exp Mol Pathol       Date:  2015-11-10       Impact factor: 3.362

  6 in total
  1 in total

1.  Observation of Clinicopathologic Features of Pituitary Adenoma With Neuronal Differentiation.

Authors:  Limei Zheng; Xiaorong Yan; Chengcong Hu; Peng Zhang; Yupeng Chen; Qiaoyan Zheng; Liwen Hu; Mi Wang; Guoping Li; Ping Wu; Changzhen Jiang; Jing Tian; Sheng Zhang; Xingfu Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-15       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.